top of page
Shop
HEALTHCARE
INSIGHTS
Log In
Anchor 1
Shop
Sun Oct 19 2025
HEALTHCARE
INSIGHTS
LIFE SCIENCES | BUSINESS | MEDICINE | HEALTHCARE
Subscribe
All Articles
Biopharma
Novel Research
Policy
Interviews
M&A
Genetics
Business
Economics
Medicine
Innovation
Funding
FDA
Search
Log in / Sign up
Jul 11
Biopharma
Biopharma's Biggest Bets in 2025 Are All About M&A
May 28
M&A
Healthcare VC's New Playbook: AI, Profitability, & Value
May 23
M&A
Pfizer’s $6 Billion Bet on China-Made Combination Cancer Therapy
Mar 28
Biopharma
AstraZeneca’s Esobiotec Acquisition: A Move on Cell Therapy
Feb 26
Biopharma
Eli Lilly Acquires Organovo’s FXR Agonist for Up to $50 Million, Sparking Stock Surge
Aug 14, 2024
M&A
Big Pharma's Billion-Dollar Bet
HEALTHCARE
INSIGHTS
NEW YORK
GROUP
| COMPANY
LIFE SCIENCES
| TOPICS
INTERVIEWS
| FEATURES
OUR STANDARDS
NOVEL RESEARCH
GUIDES
LEGAL
BUSINESS
SUBSCRIBE
PRESS
CONTACT
TERMS
POLICY
ECONOMICS
BIOPHARMA
© 2024 HEALTHCARE INSIGHTS
bottom of page
